Company Profile
Stryker Stock Price, News & Analysis
- Ticker:
- SYK
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
337.43 USD (+0.12%)
Close
Last updated: August 6, 2026
112B USD
Market cap
Why the stock is moving
The latest company update was “Stryker declares an $0.88 per share quarterly dividend”. SYK changed 0.32% and closed at $337.03 on Aug 5, 2026, indicating a relatively limited closing-price reaction to this earnings update.
Company overview
Global MedTech Leader
Stryker is a global medical technology company offering products and services across MedSurg, Neurotechnology, and Orthopaedics. Its scale, global customer base, and product breadth make it one of the largest diversified medtech companies, with products that support surgical procedures, hospital workflows, orthopedic reconstruction, and neurotechnology care.
MedSurg and Neurotechnology Engine
MedSurg and Neurotechnology is Stryker's largest segment, generating $3.6 billion in second-quarter 2026 net sales. Growth was driven mainly by unit volume, showing continued demand across the company's procedural and hospital-facing technology portfolio.
Orthopaedics Franchise
Orthopaedics remains a major growth pillar, with $3.0 billion in second-quarter sales and strong organic growth. Stryker also reorganized elements of its orthopaedic instruments, neuro cranial, spine enabling technologies, and related portfolios to better align with internal reporting and business management.
Operational Resilience
The quarter also reflected recovery from a cyber incident reported earlier in 2026. Despite that disruption, Stryker delivered strong sales, EPS, and operating cash flow growth. This supports the company's positioning as a resilient medtech operator with a steady cadence of innovation and disciplined execution.
Future catalysts
Recent news
- 01
Stryker declares an $0.88 per share quarterly dividend
Source: Stryker
- 02
Stryker reports second quarter 2026 operating results
Source: Stryker
- 03
Stryker to announce second quarter 2026 financial results
Source: Stryker
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Stryker (SYK)?
Stryker (SYK) most recently closed at 337.43 USD, a +0.12% move versus the previous session.
What is the market cap of Stryker (SYK)?
Stryker currently has a market capitalization of 112B USD on BioPharmSignal.
What does Stryker do?
Global MedTech Leader Stryker is a global medical technology company offering products and services across MedSurg, Neurotechnology, and Orthopaedics. Its scale, global customer base, and product breadth make it one of the largest diversified medtech companies, with products that support surgical procedures, hospital workflows, orthopedic reconstruction,...
On which exchange is SYK stock listed?
Stryker (SYK) is associated with NYSE, United States, Biopharma.
What is Global?
Global MedTech Leader Stryker is a global medical technology company offering products and services across MedSurg, Neurotechnology, and Orthopaedics.
Which conditions is Stryker targeting with Global?
Global MedTech Leader Stryker is a global medical technology company offering products and services across MedSurg, Neurotechnology, and Orthopaedics. Its scale, global customer base, and product breadth make it one of the largest diversified medtech companies, with products that support surgical procedures, hospital workflows, orthopedic reconstruction,...
What is MedTech?
Global MedTech Leader Stryker is a global medical technology company offering products and services across MedSurg, Neurotechnology, and Orthopaedics.
What is Leader?
Global MedTech Leader Stryker is a global medical technology company offering products and services across MedSurg, Neurotechnology, and Orthopaedics.